Fusion event
HBV-TDRD9 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCAT| |AAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTG
End
104473098/104006761 (Hg38)
Nearest miRNA
hsa-mir-1185-1/Upstream/1467035; hsa-mir-12121/Downstream/110644;
Upstream sequence
GAAGAATTTTTTTGCAATGCCTTTCCGGCAGCATCTCGATGGATATAGGTACTGAACATTCATATTTTAAAGTGTCACTGTATTTTAATGGTATTGAATG
Downstream sequence
ACACTGTTATCTGTTTATAGGAACAAAGTGAATTTCTCTGGCAGTAGCAAGAGTGACTGTATTGCACTTGTTGAGGCATTTAAAGTAAGTTTTCTGTTGT
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.